Skip to main content
Screener/Healthcare/Biotechnology

ERNA Ernexa Therapeutics Inc.

NASDAQ
$6.35+0.46 (+7.81%)
$0.13
$15.88
$5.66
$6.50
EPS (TTM)$-30.70
P/E Ratio-0.11
Dividend Yield
Market Cap$2.3M
Volume31K
Prev Close$5.89
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q1 '26$0-$5.5M$-6.95
Q4 '25$0-$1.5M$-4.75
Q3 '25$0-$1.2M$-3.75
Q2 '25$0-$3.1M$-15.25
Q1 '25$0-$8.2M$-3.75
Q4 '24$1K-$5.8M$-10.50100.0%-575900.0%
Q3 '24$487K-$26.6M$-123.00112.3%-5462.8%
Q2 '24$47K-$5.5M$-25.50-102.1%-11763.8%
Get Your Daily Market Recap